Noticias de TEM_US
Noticias del mercado
Últimas noticias sobre TEM_US — 794 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Tempus AI releases a study published in Heart Rhythm that validates its FDA-approved software for predicting Afib risk.
Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Ryan Fukushima sold 14,286 shares of the business
While traders pointed to external clinical-trial momentum as a major catalyst, Tempus's own recent guidance raise and narrowing losses provided the underlying backdrop. Tempus AI (TEM) stock rose 9.1% on Friday, August 21, its third outsized session in a row, after 24.1% and 8.8% in the two before it.
We wouldn't blame Tempus AI, Inc. ( NASDAQ:TEM ) shareholders if they were a little worried about the fact that Eric...
Página 15 de 40